期刊
DRUG DESIGN DEVELOPMENT AND THERAPY
卷 16, 期 -, 页码 3663-3673出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/DDDT.S366112
关键词
alphavirus; vector vaccines; inactivated virus; nucleic acid vaccines; immune response; arthralgia
CHIKV is a virus that has spread globally in the last twenty years. Although mortality is low, infection can result in long-term joint pain. Currently, there are no licensed treatments or preventive vaccines against CHIKV infections. However, there have been promising vaccine candidates developed in recent years.
Chikungunya virus (CHIKV) is an alphavirus that has spread globally in the last twenty years. Although mortality is rather low, infection can result in debilitating arthralgia that can persist for years. Unfortunately, no treatments or preventive vaccines are currently licensed against CHIKV infections. However, a large range of promising preclinical and clinical vaccine candidates have been developed during recent years. This review will give an introduction into the biology of CHIKV and the immune responses that are induced by infection, and will summarize CHIKV vaccine development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据